Hester Biosciences Ltd Reports Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2012
January 29, 2013
Share
Hester Biosciences Ltd. reported unaudited standalone earnings results for the third quarter and nine months ended December 31, 2012. For the quarter, on standalone basis, the company reported net sales/income from operations of INR 187.01 million against INR 117.75 million a year ago. Profit from operations before other income, finance cost and exceptional items was INR 59.58 million against INR 40.91 million a year ago. Profit from ordinary activities before tax was INR 51.47 million against INR 34.47 million a year ago. Net profit from ordinary activities after tax and net profit for the period was INR 27.65 million or INR 3.25 per basic and diluted share against net profit for the period of INR 26.31 million or INR 5.07 per basic and diluted share a year ago.
For the nine months, on standalone basis, the company reported net sales/income from operations of INR 480.81 million against INR 347.99 million a year ago. Profit from operations before other income, finance cost and exceptional items was INR 149.91 million against INR 127.19 million a year ago. Profit from ordinary activities before tax was INR 127.35 million against INR 106.37 million a year ago. Net profit from ordinary activities after tax and net profit for the period was INR 72.16 million or INR 8.48 per basic and diluted share against net profit for the period of INR 73.65 million or INR 14.19 per basic and diluted share a year ago.
Hester Biosciences Limited is an India-based animal healthcare company. The Company is engaged in providing vaccines, health products and diagnostic laboratory services. The Company operates through four segments: Poultry Healthcare, Animal Healthcare, Petcare, and Others. The Animal Healthcare vaccines include Goat Pox Vaccine, Live Brucella, PPR Vaccine - Nigerian 75/1, and PPR Vaccine - Sungri/96. Its Poultry Healthcare products include Gumboro I, Gumboro I +, Inactivated Chick ND, Inactivated Coryza, Inactivated Coryza+, Inactivated EDS, Inactivated FC3, Inactivated FC4, Inactivated IB, Inactivated IB+, Inactivated IB-H52, Inactivated IBD, Inactivated IBD ND, Inactivated IBD ND EDS, Inactivated ND IB, Inactivated Pullet ND, Live B1, Live B1 M48, Live FP, Live H120, Live Las, Live Las Mas, Live M48, Live R2B, Live S-One, MD-Bivalent HVT+SB1, MD-HVT (FD), and Thermostable ND. Its Petcare products include Cefshot Tazo Injection, Hestacef CV, Hestacef DS, Hestaflam Tablet and Hestaliv.